Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction. The article presents a clinical case of a robot-assisted extended left-sided radical nephrectomy with removal of conglomerate of the lymph nodes with preliminary renal artery embolization in a patient with histologically verified papillary kidney cancer; the technique of the operation is described, the main perioperative indicators are presented. The purpose of the study is to share the experience gained from a unique case. Materials and methods. Patient 21 years old, female. The patient had a history of macrohematuria in October 2018, and therefore was hospitalized in a city hospital, where examination, according to ultrasound, CT, revealed the formation of the left kidney. In November 2018, a targeted biopsy of a tumor of the left kidney was performed under ultrasound control; pathomorphological examination revealed papillary carcinoma. According to CT: In the upper and middle third of the left kidney, there wsa hypervascular, heterogeneous cystic-solid formation with an uneven contour, 52 × 44 × 49 mm in size, spreading into the abdominal system of the kidney, compressing the tail of the pancreas (without distinct signs of invasion), also the thrombosis of the branches of the renal vein pathomorphological was determined. A robot-assisted extended left-sided radical nephrectomy with removal of conglomerate of the lymph nodes with preliminary renal artery embolization was performed. Results. The duration of the first stage of the operation (endovascular embolization of a. renalis sinistra) was 50 minutes. The duration of the second stage of the operation (robotic radical nephrectomy) was 225 minutes. Console time is 180 minutes. The volume of blood loss did not exceed 100 ml. There were no major complications during postoperative period. Conclusions. The combination of preliminary renal artery embolization and a robot-assisted extended radical nephrectomy is an effective and safe method of surgical treatment in high-risk patients.
Introduction. The article presents a clinical case of a robot-assisted extended left-sided radical nephrectomy with removal of conglomerate of the lymph nodes with preliminary renal artery embolization in a patient with histologically verified papillary kidney cancer; the technique of the operation is described, the main perioperative indicators are presented. The purpose of the study is to share the experience gained from a unique case. Materials and methods. Patient 21 years old, female. The patient had a history of macrohematuria in October 2018, and therefore was hospitalized in a city hospital, where examination, according to ultrasound, CT, revealed the formation of the left kidney. In November 2018, a targeted biopsy of a tumor of the left kidney was performed under ultrasound control; pathomorphological examination revealed papillary carcinoma. According to CT: In the upper and middle third of the left kidney, there wsa hypervascular, heterogeneous cystic-solid formation with an uneven contour, 52 × 44 × 49 mm in size, spreading into the abdominal system of the kidney, compressing the tail of the pancreas (without distinct signs of invasion), also the thrombosis of the branches of the renal vein pathomorphological was determined. A robot-assisted extended left-sided radical nephrectomy with removal of conglomerate of the lymph nodes with preliminary renal artery embolization was performed. Results. The duration of the first stage of the operation (endovascular embolization of a. renalis sinistra) was 50 minutes. The duration of the second stage of the operation (robotic radical nephrectomy) was 225 minutes. Console time is 180 minutes. The volume of blood loss did not exceed 100 ml. There were no major complications during postoperative period. Conclusions. The combination of preliminary renal artery embolization and a robot-assisted extended radical nephrectomy is an effective and safe method of surgical treatment in high-risk patients.
Purpose: to conduct a comparative assessment of the effectiveness and safety of laparoscopic kidney resections for benign and malignant neoplasms with and without vascular isolation of the organ. Materials and methods: the research presents a comparative analysis of the direct results of treatment of 182 patients who underwent laparoscopic kidney resection. Among them there were 94 men (51,7 %) and 88 women (48,3 %). The average age was 61,6 ± 6,2 years. Two main methods were used: kidney resection with vascular isolation and without vascular ischemia. Surgical treatment was performed for malignant neoplasms in 152 cases (86,5 %) and for benign neoplasms in 24 cases (13,6 %). We used the methods of laparoscopic resection of the kidney with total vascular ischemia in 44 cases (24,2 %) and without vascular ischemia in 138 patients (75,8 %). Results: the average duration of surgery was 80 ± 18,5 minutes. The average duration of the operation with the use of vascular ischemia was 122,1 ± 17,5 minutes, without ischemia — 81,7 ± 10,6 minutes. The volume of intraoperative blood loss averaged 174,4 ± 20,1 ml, while this indicator when using the ischemic-free technique was 154,2 ± 15,7 ml, which is 32,9 % less (p> 0,05) than in cases with the use of vascular isolation (230,1 ± 20,8 ml). When using the technique of vascular isolation, the serum creatinine has increased for 16,2 ± 1,7 μmol / L (16,7 %), without vascular isolation 6,5 ± 1,5 μmol / L (6,7 %). Conclusion: laparoscopic kidney resections without vascular isolation are characterized by a lower volume of intraoperative blood loss, a shorter operation time and are not accompanied by an increase in the number of postoperative complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.